INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 187 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8 | -33.3% | 20,501 | -22.9% | 0.00% | – |
| Q2 2023 | $12 | -69.2% | 26,603 | -44.0% | 0.00% | – |
| Q1 2023 | $39 | -45.1% | 47,509 | +4.6% | 0.00% | – |
| Q4 2022 | $71 | -99.9% | 45,406 | +14.1% | 0.00% | – |
| Q3 2022 | $69,000 | +3.0% | 39,785 | +2.3% | 0.00% | – |
| Q2 2022 | $67,000 | -72.4% | 38,885 | -42.6% | 0.00% | -100.0% |
| Q1 2022 | $243,000 | -26.6% | 67,766 | +2.1% | 0.00% | 0.0% |
| Q4 2021 | $331,000 | -45.9% | 66,341 | -22.4% | 0.00% | -66.7% |
| Q3 2021 | $612,000 | -24.4% | 85,436 | -2.2% | 0.00% | -25.0% |
| Q2 2021 | $810,000 | -10.1% | 87,378 | -10.1% | 0.00% | -20.0% |
| Q1 2021 | $901,000 | +25.1% | 97,141 | +19.3% | 0.01% | +25.0% |
| Q4 2020 | $720,000 | -30.4% | 81,407 | -8.8% | 0.00% | -42.9% |
| Q3 2020 | $1,035,000 | -28.6% | 89,246 | +66.0% | 0.01% | -36.4% |
| Q2 2020 | $1,449,000 | +1734.2% | 53,766 | +405.1% | 0.01% | +1000.0% |
| Q1 2020 | $79,000 | +192.6% | 10,644 | -18.1% | 0.00% | – |
| Q3 2019 | $27,000 | -28.9% | 12,994 | +1.6% | 0.00% | – |
| Q2 2019 | $38,000 | -20.8% | 12,794 | 0.0% | 0.00% | – |
| Q1 2019 | $48,000 | +2.1% | 12,794 | +8.5% | 0.00% | -100.0% |
| Q4 2018 | $47,000 | -28.8% | 11,794 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $66,000 | +57.1% | 11,794 | +9.3% | 0.00% | – |
| Q2 2018 | $42,000 | -25.0% | 10,794 | -8.5% | 0.00% | -100.0% |
| Q1 2018 | $56,000 | +21.7% | 11,794 | +6.3% | 0.00% | 0.0% |
| Q4 2017 | $46,000 | -27.0% | 11,094 | +10.8% | 0.00% | 0.0% |
| Q3 2017 | $63,000 | -20.3% | 10,015 | -0.8% | 0.00% | 0.0% |
| Q2 2017 | $79,000 | -66.9% | 10,093 | -58.4% | 0.00% | -85.7% |
| Q3 2014 | $239,000 | – | 24,258 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
| Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
| Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
| Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
| PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
| Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
| Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
| Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
| Beck Bode, LLC | 41,218 | $33,799 | 0.01% |